Ajanta Pharma

Ajanta got FDA approval for generic equivalent of brand glumetza (metformin hydrochloride; extended release tablets). US sales for these was ~$192 mn for 12-months ending November 2020 (link). One theme evolving out of Ajanta’s US portfolio is their focus on slightly complicated delivery methods (like extended release, delayed release, etc.) in oral solids.

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213962

Disclosure: Invested (position size here)

4 Likes